tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IBRX Stock Latest News

Unusually active option classes on open January 9th
The FlyUnusually active option classes on open January 9th
2d ago
FNF
LDI
ImmunityBio publishes Anktiva plus Bacillus Calmette-Guerin data
PremiumThe Fly
ImmunityBio publishes Anktiva plus Bacillus Calmette-Guerin data
26d ago
IBRX
ImmunityBio Appoints Bruce Wendel to Board
PremiumCompany Announcements
ImmunityBio Appoints Bruce Wendel to Board
26d ago
8K
IBRX
ImmunityBio’s HCW9218 Study Completion: A Potential Game-Changer for Pancreatic Cancer Treatment
PremiumCompany Announcements
ImmunityBio’s HCW9218 Study Completion: A Potential Game-Changer for Pancreatic Cancer Treatment
28d ago
IBRX
ImmunityBio price target raised to $9 from $8 at Jefferies
PremiumThe Fly
ImmunityBio price target raised to $9 from $8 at Jefferies
30d ago
IBRX
ImmunityBio’s Strategic and Regulatory Progress Fuels Buy Rating
PremiumRatingsImmunityBio’s Strategic and Regulatory Progress Fuels Buy Rating
30d ago
IBRX
ImmunityBio’s Strategic Advancements and Market Potential Drive Buy Rating
Premium
Ratings
ImmunityBio’s Strategic Advancements and Market Potential Drive Buy Rating
30d ago
IBRX
ImmunityBio Gains EMA Nod for ANKTIVA® in Europe
Premium
Company Announcements
ImmunityBio Gains EMA Nod for ANKTIVA® in Europe
30d ago
8K
IBRX
ImmunityBio: EMA recommends marketing authorization in EU for ANKTIVA with BCG
PremiumThe Fly
ImmunityBio: EMA recommends marketing authorization in EU for ANKTIVA with BCG
30d ago
IBRX
ImmunityBio Reports Revenue Surge Amid Financial Challenges
PremiumCompany Announcements
ImmunityBio Reports Revenue Surge Amid Financial Challenges
2M ago
IBRX
ImmunityBio reports Q3 EPS (7c), consensus (11c)
PremiumThe Fly
ImmunityBio reports Q3 EPS (7c), consensus (11c)
2M ago
IBRX
Unusually active option classes on open October 1st
PremiumThe Fly
Unusually active option classes on open October 1st
3M ago
AES
BMY
Citizens JMP healthcare analysts hold an analyst/industry conference call
PremiumThe FlyCitizens JMP healthcare analysts hold an analyst/industry conference call
4M ago
JNJ
CGON
Promising Developments in ImmunityBio’s ANKTIVA for NSCLC: A Buy Rating Based on Lymphorestorative Potential and Broader Oncology Applications
Premium
Ratings
Promising Developments in ImmunityBio’s ANKTIVA for NSCLC: A Buy Rating Based on Lymphorestorative Potential and Broader Oncology Applications
4M ago
IBRX
Buy Rating for ImmunityBio’s ANKTIVA: Promising Phase II Results and Potential Biomarker Identification
Premium
Ratings
Buy Rating for ImmunityBio’s ANKTIVA: Promising Phase II Results and Potential Biomarker Identification
4M ago
IBRX
Citizens JMP healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
4M ago
JNJ
CGON
ImmunityBio study shows ANKTIVA reverses lymphopenia, extends survival
PremiumThe Fly
ImmunityBio study shows ANKTIVA reverses lymphopenia, extends survival
4M ago
IBRX
ImmunityBio’s Anktiva: A Promising Treatment for Long COVID?
PremiumCompany Announcements
ImmunityBio’s Anktiva: A Promising Treatment for Long COVID?
4M ago
IBRX
ImmunityBio’s Innovative Phase 2 Lymphoma Study: A Potential Game-Changer?
PremiumCompany Announcements
ImmunityBio’s Innovative Phase 2 Lymphoma Study: A Potential Game-Changer?
4M ago
IBRX
ImmunityBio announces early findings from Anktiva pilot study
PremiumThe FlyImmunityBio announces early findings from Anktiva pilot study
5M ago
IBRX
ImmunityBio announces Anktiva trial
Premium
The Fly
ImmunityBio announces Anktiva trial
5M ago
IBRX
ImmunityBio’s Anktiva Study: A Potential Breakthrough for Long COVID Treatment
Premium
Company Announcements
ImmunityBio’s Anktiva Study: A Potential Breakthrough for Long COVID Treatment
5M ago
IBRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >